Literature DB >> 15703936

Treatment of segmental bone defects in rats by the stimulation of bone marrow osteo-progenitor cells with prostaglandin E2.

A M Ozturk1, E Cila, U Kanatli, I Isik, A Senkoylu, D Uzunok, E Piskin.   

Abstract

An alternative to bone grafting is engineered osteo-conductive material that carries osteo-progenitor cells with osteo-stimulant factors impregnated on a malleable osteo-conductive material. We used bone marrow stem cells as the source of osteo-progenitor cells and stimulated them with prostaglandin E2 using demineralised bone matrix as a carrier. We treated 35 skeletally mature male Wistar albino rats with segmentary radial bone defects using five different treatment groups. Group I received no treatment; the remaining four groups all received a mixture of bone marrow and demineralised bone matrix. In group III, a copolymer was added. In group IV, prostaglandin E2 and in group V prostaglandin E2 within a copolymer was added to the mixture. Eight weeks after the surgical procedure, the rats were sacrificed. Radiological and histological evaluation of the radial bone showed that while there was no significant healing in groups I, II and III, there was a significant healing response in groups IV and V.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703936      PMCID: PMC3474507          DOI: 10.1007/s00264-004-0623-5

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  22 in total

Review 1.  Bone graft materials. An overview of the basic science.

Authors:  T W Bauer; G F Muschler
Journal:  Clin Orthop Relat Res       Date:  2000-02       Impact factor: 4.176

2.  STUDIES IN THE TRANSPLANTATION OF BONE. VII. THE FRESH COMPOSITE HOMOGRAFT-AUTOGRAFT OF CANCELLOUS BONE; AN ANALYSIS OF FACTORS LEADING TO OSTEOGENESIS IN MARROW TRANSPLANTS AND IN MARROW-CONTAINING BONE GRAFTS.

Authors:  R G BURWELL
Journal:  J Bone Joint Surg Br       Date:  1964-02

3.  Autologous marrow injection as a substitute for operative grafting of tibial nonunions.

Authors:  J F Connolly; R Guse; J Tiedeman; R Dehne
Journal:  Clin Orthop Relat Res       Date:  1991-05       Impact factor: 4.176

4.  Biology of bone transplantation.

Authors:  H Burchardt
Journal:  Orthop Clin North Am       Date:  1987-04       Impact factor: 2.472

5.  Current approaches to experimental bone grafting.

Authors:  J M Lane; H S Sandhu
Journal:  Orthop Clin North Am       Date:  1987-04       Impact factor: 2.472

6.  Bridging large defects in bone by demineralized bone matrix in the form of a powder. A radiographic, histological, and radioisotope-uptake study in rats.

Authors:  R Gepstein; R E Weiss; T Hallel
Journal:  J Bone Joint Surg Am       Date:  1987-09       Impact factor: 5.284

7.  Extraskeletal and intraskeletal new bone formation induced by demineralized bone matrix combined with bone marrow cells.

Authors:  T S Lindholm; O S Nilsson; T C Lindholm
Journal:  Clin Orthop Relat Res       Date:  1982 Nov-Dec       Impact factor: 4.176

8.  Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs.

Authors:  J J Tiedeman; J F Connolly; B S Strates; L Lippiello
Journal:  Clin Orthop Relat Res       Date:  1991-07       Impact factor: 4.176

9.  Poly(D,L-lactide/epsilon-caprolactone)/hydroxyapatite composites.

Authors:  E Ural; K Kesenci; L Fambri; C Migliaresi; E Piskin
Journal:  Biomaterials       Date:  2000-11       Impact factor: 12.479

10.  The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks.

Authors:  J Goshima; V M Goldberg; A I Caplan
Journal:  Clin Orthop Relat Res       Date:  1991-01       Impact factor: 4.176

View more
  8 in total

1.  Osteogenic differentiation is synergistically influenced by osteoinductive treatment and direct cell-cell contact between murine osteoblasts and mesenchymal stem cells.

Authors:  Ming-Tzu Tsai; Dan-Jae Lin; Sherry Huang; Hsiu-Ting Lin; Walter H Chang
Journal:  Int Orthop       Date:  2011-05-13       Impact factor: 3.075

2.  Demineralized bone matrix and hydroxyapatite/tri-calcium phosphate mixture for bone healing in rats.

Authors:  Ali Oztürk; H Yetkin; L Memis; E Cila; S Bolukbasi; Halil Can Gemalmaz
Journal:  Int Orthop       Date:  2006-03-25       Impact factor: 3.075

Review 3.  Bone marrow derived stem cells in joint and bone diseases: a concise review.

Authors:  Antonio Marmotti; Laura de Girolamo; Davide Edoardo Bonasia; Matteo Bruzzone; Silvia Mattia; Roberto Rossi; Angela Montaruli; Federico Dettoni; Filippo Castoldi; Giuseppe Peretti
Journal:  Int Orthop       Date:  2014-07-09       Impact factor: 3.075

4.  Vitamin-D binding protein does not enhance healing in rat bone defects: a pilot study.

Authors:  Jui-Sheng Sun; Pei-Yu Chen; Yang-Hwei Tsuang; Ming-Hong Chen; Po-Quang Chen
Journal:  Clin Orthop Relat Res       Date:  2009-05-06       Impact factor: 4.176

Review 5.  Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments.

Authors:  Spyros G Pneumaticos; Georgios K Triantafyllopoulos; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  J Cell Mol Med       Date:  2010-11       Impact factor: 5.310

6.  Effects of prostaglandin E1 on callus formation in rabbits.

Authors:  Pawel V Lipinsky; Ivan V Sirotin; Alexandr V Skoroglyadov; Alexey V Ivkov; Alexandr P Oettinger; Evgeny E Krynetskiy; Alexandr B But-Gusaim; Andreas J Roth
Journal:  BMC Musculoskelet Disord       Date:  2015-09-10       Impact factor: 2.362

Review 7.  A Concise Review on the Use of Mesenchymal Stem Cells in Cell Sheet-Based Tissue Engineering with Special Emphasis on Bone Tissue Regeneration.

Authors:  A Cagdas Yorukoglu; A Esat Kiter; Semih Akkaya; N Lale Satiroglu-Tufan; A Cevik Tufan
Journal:  Stem Cells Int       Date:  2017-11-05       Impact factor: 5.443

Review 8.  Role of prostaglandin E2 in tissue repair and regeneration.

Authors:  Hui Cheng; Haoyan Huang; Zhikun Guo; Ying Chang; Zongjin Li
Journal:  Theranostics       Date:  2021-08-13       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.